1. Home
  2. TECX vs FCEL Comparison

TECX vs FCEL Comparison

Compare TECX & FCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$33.31

Market Cap

393.0M

Sector

N/A

ML Signal

HOLD

Logo FuelCell Energy Inc.

FCEL

FuelCell Energy Inc.

HOLD

Current Price

$6.63

Market Cap

370.1M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
FCEL
Founded
2019
1969
Country
United States
United States
Employees
51
629
Industry
Industrial Machinery/Components
Sector
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
393.0M
370.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TECX
FCEL
Price
$33.31
$6.63
Analyst Decision
Strong Buy
Hold
Analyst Count
5
4
Target Price
$80.40
$8.31
AVG Volume (30 Days)
380.4K
1.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$18.91
Revenue Next Year
N/A
$35.84
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.70
$3.58
52 Week High
$35.99
$11.99

Technical Indicators

Market Signals
Indicator
TECX
FCEL
Relative Strength Index (RSI) 67.84 38.96
Support Level $16.83 $6.35
Resistance Level $35.99 $10.69
Average True Range (ATR) 2.81 0.65
MACD 0.91 -0.15
Stochastic Oscillator 80.72 1.80

Price Performance

Historical Comparison
TECX
FCEL

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About FCEL FuelCell Energy Inc.

FuelCell Energy Inc is a clean energy technology company engaged in the development, design, production, and servicing of high temperature fuel cells for clean electric power generation. The Company provides proprietary molten carbonate fuel cell systems that generate electricity electrochemically with ultra low emissions and high efficiency, and operates as a solutions provider managing the design, manufacturing, installation, and maintenance of its systems under long term power purchase, service, and engineering procurement agreements. The Company serves utilities, data centers, and commercial and industrial customers, and operates in the United States, South Korea, Europe, and Canada, with maximum revenue generated from the United States.

Share on Social Networks: